Seegene, "The Real Special is in Q2" Stock Price 131,400 KRW (2.02%)

As of 9:30 AM on the 15th, Seegene is trading at 131,400 KRW, up 2.02% from the previous day. The trading volume is 3,734,468 shares, which is 19.14% of the previous day's volume. Seegene is known as a company that develops, manufactures, and sells molecular diagnostic reagents.

On May 14, KTB Investment & Securities researcher Kang Ha-young stated, "Due to the global spread of COVID-19, 1) sales of COVID-19 diagnostic kits have occurred, 2) equipment sales have increased due to acquiring new customers, and 3) sales of existing reagents have surged, initiating structural improvement. Considering the enhanced position in existing markets such as Europe and expansion into new markets like South America and the United States, as well as the spread of COVID-19, there is a high possibility of upward revision in estimated performance." He set Seegene's target price at 130,000 KRW.

Over the past five days, individual investors have net sold 966,219 shares of Seegene, while foreigners and institutions have net bought 162,127 shares and 793,469 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.